Showing results (1861-1870 of 1,938) with videos related to
Sort By:
Pageof 194
The Journal of Allergy and Clinical Immunology|October 9, 2016
Proton pump inhibitors decrease eotaxin-3/CCL26 expression in patients with chronic rhinosinusitis with nasal polyps: Possible role of the nongastric H,K-ATPaseJin-Young Min, Christopher J Ocampo, Whitney W Stevens, et al.Journal of Medicinal Chemistry|March 27, 2009
1-Sulfonyl-4-acylpiperazines as selective cannabinoid-1 receptor (CB1R) inverse agonists for the treatment of obesityPetr Vachal, Joan M Fletcher, Tung M Fong, et al.Annals of Surgical Oncology|November 15, 2023
Role of Concurrent Ultrasound Surveillance of Sentinel Node-Positive Node Fields in Melanoma Patients Having Routine Cross-Sectional ImagingCaroline A Gjorup, Rachel Woodford, Isabel Li, et al.Cancer Cell|February 13, 2019
Distinct Immune Cell Populations Define Response to Anti-PD-1 Monotherapy and Anti-PD-1/Anti-CTLA-4 Combined TherapyTuba N Gide, Camelia Quek, Alexander M Menzies, et al.Annals of Surgical Oncology|March 11, 2020
International Multicenter Experience of Isolated Limb Infusion for In-Transit Melanoma Metastases in Octogenarian and Nonagenarian PatientsJüri Teras, Hidde M Kroon, John T Miura, et al.Annals of Surgical Oncology|May 2, 2022
Oncologic Outcomes of Multi-Institutional Minimally Invasive Inguinal Lymph Node Dissection for Melanoma Compared with Open Inguinal Dissection in the Second Multicenter Selective Lymphadenectomy Trial (MSLT-II)James W Jakub, Michael Lowe, J Harrison Howard, et al.Trials|May 5, 2021
Can patient-led surveillance detect subsequent new primary or recurrent melanomas and reduce the need for routinely scheduled follow-up? A protocol for the MEL-SELF randomised controlled trialDeonna M Ackermann, Amelia K Smit, Monika Janda, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 26, 2019
Adjuvant Whole-Brain Radiation Therapy Compared With Observation After Local Treatment of Melanoma Brain Metastases: A Multicenter, Randomized Phase III TrialAngela M Hong, Gerald B Fogarty, Kari Dolven-Jacobsen, et al.European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|August 3, 2020
Factors predicting toxicity and response following isolated limb infusion for melanoma: An international multi-centre studyTimothy J Kenyon-Smith, Hidde M Kroon, John T Miura, et al.Nature Communications|February 19, 2021
Tumour gene expression signature in primary melanoma predicts long-term outcomesManik Garg, Dominique-Laurent Couturier, Jérémie Nsengimana, et al.Pageof 194